Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy–related cardiomyopathy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy–related cardiomyopathy
Authors
Keywords
-
Journal
MUSCLE & NERVE
Volume 64, Issue 2, Pages 163-171
Publisher
Wiley
Online
2021-06-04
DOI
10.1002/mus.27336
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiorespiratory progression over 5 years and role of corticosteroids in DMD: a single site retrospective longitudinal study
- (2020) Federica Trucco et al. CHEST
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Study of Duchenne muscular dystrophy long-term survivors aged 40 years and older living in specialized institutions in Japan
- (2017) Toshio Saito et al. NEUROMUSCULAR DISORDERS
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dystrophin-Deficient Cardiomyopathy
- (2016) Forum Kamdar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial
- (2015) Subha V Raman et al. LANCET NEUROLOGY
- Cardiac phenotype determines survival in Duchenne muscular dystrophy
- (2015) David J. Birnkrant et al. PEDIATRIC PULMONOLOGY
- Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging
- (2014) A. Florian et al. European Heart Journal-Cardiovascular Imaging
- All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
- (2013) Gernot Schram et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy
- (2012) Laurence Viollet et al. AMERICAN JOURNAL OF CARDIOLOGY
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Detection of Progressive Cardiac Dysfunction by Serial Evaluation of Circumferential Strain in Patients With Duchenne Muscular Dystrophy
- (2010) Sean C. Hagenbuch et al. AMERICAN JOURNAL OF CARDIOLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
- Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy
- (2008) Hitoko Ogata et al. Journal of Cardiology
- Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy
- (2008) Larry W. Markham et al. NEUROMUSCULAR DISORDERS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started